(Q37465508)
English
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumato
scientific article published on 31 July 2013
Statements
1 reference
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumato (English)
1 reference
Gerd R Burmester
1 reference
Madura J Rangaraj
1 reference
Georgia Roane
1 reference
Charles Ludivico
1 reference
Lucy Rowell
1 reference
Eduardo F Mysler
1 reference
Andrea Rubbert-Roth
1 reference
Alain Cantagrel
1 reference
Stephen Hall
1 reference
Piotr Leszczynski
1 reference
Daniel Feldman
1 reference
Peng Lu
1 reference
Min Bao
1 reference
31 July 2013
1 reference
1 reference
69-74
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference